Caitong International Asset Management’s Celldex Therapeutics CLDX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	$1.59K	Buy	78 +46	+144%	+$936	﹤0.01%	1450
2025 Q1	$581	Buy	+32	New	+$581	﹤0.01%	1729